Zenotech Laboratories (BOM:532039) Research & Development: ₹0.0 Mil (TTM As of Mar. 2026)


BOM:532039 Zenotech Laboratories Ltd BOM:532039
73 GF Score
Price ₹45.91
GF Value ₹65.19
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Zenotech Laboratories Research & Development?

Zenotech Laboratories BOM:532039 +3.42% 73 Research & Development is ₹0.0 Mil as of Mar. 2026. GuruFocus rates BOM:532039 with a GF Score™ of 73/100 and a GF Value™ of ₹65.19 (Significantly Undervalued). The stock has 1 warning sign investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Zenotech Laboratories's Research & Development for the three months ended in Mar. 2026 was ₹0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.0 Mil.

Zenotech Laboratories  (BOM:532039) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Zenotech Laboratories Research & Development Related Terms

Zenotech Laboratories Research & Development Historical Data

* Premium members only.

The historical data trend for Zenotech Laboratories's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zenotech Laboratories Research & Development Chart

Zenotech Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Zenotech Laboratories Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:532039
73GF Score
Zenotech Laboratories Ltd BOM:532039
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Zenotech Laboratories Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₹0.0 Mil mean?
Zenotech Laboratories (BOM:532039) has a Research & Development of ₹0.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Zenotech Laboratories and its competitors.
Is Zenotech Laboratories' Research & Development too high?
Zenotech Laboratories' current Research & Development is ₹0.0 Mil. Overall, Zenotech Laboratories has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Zenotech Laboratories' Research & Development compare to ZTS and UTHR?
Zenotech Laboratories' Research & Development of ₹0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Zenotech Laboratories and its competitors. Zenotech Laboratories's current Research & Development is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zenotech Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Zenotech Laboratories (BOM:532039) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹65.19, compared to a current price of ₹45.91 — trading 29.6% below its estimated fair value. The current Research & Development is ₹0.0 Mil. Zenotech Laboratories' overall GF Score™ is 73/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Zenotech Laboratories (BOM:532039), the current Research & Development is ₹0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Zenotech Laboratories (BOM:532039) Overvalued in 2026?

Based on GuruFocus' analysis, Zenotech Laboratories stock appears to be undervalued. The current stock price of ₹45.91 is trading 29.6% below its estimated GF Value™ of ₹65.19. GuruFocus considers Zenotech Laboratories to be Significantly Undervalued.

Key valuation signals for BOM:532039:

  • Research & Development: ₹0.0 Mil
  • GF Value™: ₹65.19 vs. price of ₹45.91 (29.6% below fair value)
  • GF Score™: 73/100 with 1 warning sign

No single metric tells the full story. See the BOM:532039 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zenotech Laboratories Business Description

Address Survey No. 250-252, Turkapally Village, Shamirpet Mandal, RR District, Hyderabad, TG, IND, 500 078
Zenotech Laboratories Ltd is an India-based pharmaceutical company. It is a pharmaceutical specialty generic injectables company engaged in the area of manufacturing biotechnology products. The Company's injectables product portfolio serves niche therapy areas like oncology and anesthesiology. It also manufactures products such as granulocyte-colony stimulating factor (GCSF) and Granulocyte-macrophage colony-stimulating factor (GMCSF). The company earns a vast majority of the revenue from the sale of its contract research and manufacturing services.
73GF Score

Get the complete analysis for BOM:532039

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹45.91
Price
₹65.19
GF Value